-
31
-
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
-
Mack, Philip C.;
Gomez, Jorge E.;
Rodilla, Ananda M.;
Carreñ
o, Juan Manuel;
Hsu, Chih-Yuan;
Rolfo, Christian;
Meshulami, Noy;
Moore, Amy;
Brody, Rachel I.;
King, Jennifer C.;
Treatman, Jacquelyn;
Lee, Sooyun;
Raskin, Ariel;
Srivastava, Komal;
Gleason, Charles R.;
de Miguel-Perez, Diego;
Tcheou, Johnstone;
Bielak, Dominika;
Acharya, Rashmi;
Gerber, David E.;
Rohs, Nicholas;
Henschke, Claudia I.;
Yankelevitz, David F.;
Simon, Viviana;
Minna, John D.;
Bunn Jr., Paul A.;
Garcí
a-Sastre, Adolfo;
Krammer, Florian;
Shyr, Yu;
Hirsch, Fred R.;
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Department of Biostatistics, Vanderbilt University, Nashville, TN, USA;
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA;
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA;
LUNGevity Foundation, Bethesda, MD, USA;
Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
GO2 Foundation for Lung Cancer, Washington, DC, USA;
Center for Thoracic Oncology, T;
(Cancer cell,
v.40,
2022,
pp.575-577)
-
32
-
First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — May 2014
-
Bialek, Stephanie R.;
Allen, Donna;
Alvarado-Ramy, Francisco;
Arthur, Ray;
Balajee, Arunmozhi;
Bell, David;
Best, Susan;
Blackmore, Carina;
Breakwell, Lucy;
Cannons, Andrew;
Brown, Clive;
Cetron, Martin;
Chea, Nora;
Chommanard, Christina;
Cohen, Nicole;
Conover, Craig;
Crespo, Antonio;
Creviston, Jeanean;
Curns, Aaron T.;
Dahl, Rebecca;
Dearth, Stephanie;
DeMaria Jr, Alfred;
Echols, Fred;
Erdman, Dean D.;
Feikin, Daniel;
Frias, Mabel;
Gerber, Susan I.;
Gulati, Reena;
Hale, Christa;
Haynes, Lia M.;
Heberlein-Larson, Lea;
Holton, Kelly;
Ijaz, Kashef;
Kapoor, Minal;
Kohl, Katrin;
Kuhar, David T.;
Kumar, Alan M.;
Kundich, Marianne;
Lippold, Susan;
Liu, Lixia;
Lovchik, Judith C.;
Madoff, Larry;
Martell, Sandra;
Matthews, Sarah;
Moore, Jessica;
Murray, Linda R.;
Onofrey, Shauna;
Pallansch, Mark A.;
Pesik, Nicki;
Pham, Huong;
Pillai, Satish;
Pontones, Pam;
Poser, Sarah;
Pringle, Kimberly;
Pritchard, Scott;
Rasmussen, Sonja;
Richards, Sha;
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC;
Indiana State Department of Health;
Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC;
Division of Global Health Protection, Center for Global Health, CDC;
Division of Global Health Protection, Center for Global Health, CDC;
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC;
Lake County Health Department, Indiana;
Florida Department of Health;
Epidemic Intelligence Service, Division of Scientific Education and Professional Development, CDC;
Florida Department of Health;
Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC;
Division of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC;
Epidemic Intelligence Service, Division of Scientific Education and Professional Development;
(Morbidity and mortality weekly report : MMWR,
v.63,
2014,
pp.431-436)
-
33
-
Tumor Cell Complementation Groups Based on Myogenic Potential: Evidence for Inactivation of Loci Required for Basic Helix-Loop-Helix Protein Activity
-
Gerber, Anthony N.;
Tapscott, Stephen J.;
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, and Department of Pathology, School of Medicine, University of Washington, Seattle, Washington 98105;
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, and Department of Pathology, School of Medicine, University of Washington, Seattle, Washington 98105;
(Molecular and cellular biology,
v.16,
1996,
pp.3901-3908)
-
34
-
Milchuntersuchung
-
Splittgerber, A.;
Jensen, O.;
Kö
stler, G.;
Burri, R.;
Staub, W.;
Gerber, N.;
Ottiker, A.;
Laxa, O.;
Kooper, W. D.;
Grimmer,;
Pritzker, J.;
v. Heygendorff,;
Meurer,;
Faitelowitz, A.;
Bordas,;
Touplain,;
Mayer, J.;
Sarthou, J.;
Spindler, F.;
Seligmann, E.;
Trommsdorff, R.;
Barthel, C;
Dons, R.;
Fred, E. B.;
Breed, S.;
Skar, O.;
Sandelin, A. E.;
Eichwald, E.;
Kufferath, H.;
Schern, K.;
Oppenheimer, S.;
Rö
mer, P. H.;
Sames, T;
Rullmann, W.;
Lee, R. E.;
Mellon, M. G.;
Schmidt, H.;
Reinhardt, R.;
Seibold, E.;
Philippe, E.;
Giffhorn, A.;
Lenzen, H.;
Stetter, A.;
Hesse,;
van Eck, J. J.;
Kastle, J. H.;
Porch, M. B.;
Herholz, B.;
de Graaf, W. C.;
Rothenfusser, S.;
Schellhase, W.;
Drost, J.;
Zilva, S. S.;
v. Baeyer, A.;
Villiger,;
Hildbrandt, A.;
Kü
hn, B.;
Grewing, B.;
Violle, H.;
Reiss, E.;
Diesselhorst, G.;
Rubner, M.;
Gaucher, L.;
Morres, W.;
Koning, C. J.;
van Haarst, J.;
Vandevelde, A. J. J.;
Rosam, A.;
;
(Zeitschrift für analytische Chemie,
v.59,
1920,
pp.462-494)
-
35
-
Modeling stochastic gene expression: Implications for haploinsufficiency
-
Cook, Daniel L.;
Gerber, Anthony N.;
Tapscott, Stephen J.;
Department of Physiology and Biophysics, University of Washington, Seattle, WA 98105;
Department of Medicine, University of California at San Francisco School of Medicine, San Francisco, CA 94122;
and Division of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
Department of Physiology and Biophysics, University of Washington, Seattle, WA 98105;
Department of Medicine, University of California at San Francisco School of Medicine, San Francisco, CA 94122;
and Division of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
Department of Physiology and Biophysics, University of Washington, Seattle, WA 98105;
Department of Medicine, University of California at San Francisco School of Medicine, San Francisco, CA 94122;
and Division of Molecular Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109;
(Proceedings of the National Academy of Sciences of the United States of America,
v.95,
1998,
pp.15641-15646)
-
36
-
Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to <i>Plasmodium falciparum</i> circumsporozoite protein
-
Raghunandan, Rama;
Mayer, Bryan T.;
Flores-Garcia, Yevel;
Gerber, Monica W.;
Gottardo, Raphael;
Jhun, Hugo;
Herrera, Sonia M.;
Perez-Ramos, Daniel W.;
Locke, Emily;
King, C. Richter;
Zavala, Fidel;
PATH’s Malaria Vaccine Initiative, 455 Massachusetts Avenue, NW, Suite 1000, Washington, DC 20001 USA;
Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA 98109 USA;
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA;
Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA 98109 USA;
Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA 98109 USA;
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA;
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD USA;
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Ba;
(Malaria journal,
v.19,
2020,
pp.113)
-
37
-
462. Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life
-
Cardemil, Cristina;
Munoz, Flor M;
Cao, Yi;
Gao, Fei;
Posavad, Christine M;
Badell, Martina L;
Bunge, Katherine E;
Mulligan, Mark J;
Parameswaran, Lalitha;
Olson-Chen, Courtney;
Novak, Richard M;
Brady, Rebecca C;
DeFranco, Emily A;
Gerber, Jeffrey S;
Pasetti, Marcela;
Shriver, Mallory C;
Coler, Rhea;
Berube, Bryan J;
Richardson, Barbra A;
Beigi, Richard H;
Neuzil, Kathy M;
Brown, Elizabeth R;
National Institutes of Health , Rockville, Maryland;
Baylor College of Medicine , Houston, TX;
Fred Hutchinson Cancer Center , Seattle, Washington;
Fred Hutchinson Cancer Center , Seattle, Washington;
Fred Hutchinson Cancer Center , Seattle, Washington;
Emory University School of Medicine , Atlanta , Georgia;
University of Pittsburgh , Pittsburgh, Pennsylvania;
NYU Grossman School of Medicine , New York, New York;
NYU Langone Health, NYU Langone Vaccine Center , New York, New York;
University of Rochester , Rochester, New York;
University of illinois at Chicago , Chicago, Illinois;
CIncinnati Children's Hospital Medical Center , Cincinnati, Ohio;
Cincinnati Children’s Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine , Cincinnati, Ohio;
Children's Hospital of Philadelphia , Philadelphia, Pennsylvania;
University of Maryland , Baltimore, Maryland;
University of Maryland School of Medicine ,;
(Open forum infectious diseases,
v.10,
2023,
pp.ofad500.532)
-
38
-
Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report
-
Couriel, Daniel;
Carpenter, Paul A.;
Cutler, Corey;
Bolañ
os-Meade, Javier;
Treister, Nathaniel S.;
Gea-Banacloche, Juan;
Shaughnessy, Paul;
Hymes, Sharon;
Kim, Stella;
Wayne, Alan S.;
Chien, Jason W.;
Neumann, Joyce;
Mitchell, Sandra;
Syrjala, Karen;
Moravec, Carina K.;
Abramovitz, Linda;
Liebermann, Jerry;
Berger, Ann;
Gerber, Lynn;
Schubert, Mary;
Filipovich, Alexandra H.;
Weisdorf, Daniel;
Schubert, Mark M.;
Shulman, Howard;
Schultz, Kirk;
Mittelman, Barbara;
Pavletic, Steven;
Vogelsang, Georgia B.;
Martin, Paul J.;
Lee, Stephanie J.;
Flowers, Mary E.D.;
;
(Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
v.12,
2006,
pp.375-396)
-
39
-
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
-
Cardemil, Cristina V.;
Cao, Yi;
Posavad, Christine M.;
Badell, Martina L.;
Bunge, Katherine;
Mulligan, Mark J.;
Parameswaran, Lalitha;
Olson-Chen, Courtney;
Novak, Richard M.;
Brady, Rebecca C.;
DeFranco, Emily;
Gerber, Jeffrey S.;
Pasetti, Marcela;
Shriver, Mallory;
Coler, Rhea;
Berube, Bryan;
Suthar, Mehul S.;
Moreno, Alberto;
Gao, Fei;
Richardson, Barbra A.;
Beigi, Richard;
Brown, Elizabeth;
Neuzil, Kathleen M.;
Munoz, Flor M.;
aNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland;
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington;
bVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington;
cDivision of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Emory University Hospital Midtown Perinatal Center, Atlanta, Georgia;
dDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women’s Hospital, Pittsburgh, Pennsylvania;
eNew York University Langone Vaccine Center, and Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, New York;
eNew York University Langone Vaccine Center, and Division of Infectious Diseases and Immuno;
(Pediatrics,
v.153,
2024,
pp.e2023064252)
-
40
-
ECOG-ACRIN LUNG-MAP S1900E substudy: A phase II study of sotorasib in participants (Pts) with previously treated stage IV or recurrent <i>KRAS</i> G12C mutant non-squamous (Non-sq) non-small cell lung cancer (NSCLC).
-
Padda, Sukhmani Kaur;
Redman, Mary Weber;
Gerber, David E;
Stinchcombe, Tom;
Waqar, Saiama Naheed;
Leal, Ticiana;
Minichiello, Katherine;
Reckamp, Karen L.;
Herbst, Roy S.;
Borghaei, Hossein;
Brahmer, Julie R.;
Gray, Jhanelle Elaine;
Kelly, Karen;
Ramalingam, Suresh S.;
Neal, Joel W.;
Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA;
SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA;
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX;
Duke Cancer Institute, Durham, NC;
Washington University School of Medicine, St. Louis, MO;
Winship Cancer Institute of Emory University, Atlanta, GA;
SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA;
Cedars-Sinai Medical Center, Los Angeles, CA;
Yale School of Medicinel, Yale Cancer Center, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT;
Fox Chase Cancer Center, Philadelphia, PA;
Johns Hopkins Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;
Moffitt Cancer Center, Tampa, FL;
UC Davis Comprehensive Cancer Center, Sacramento, CA;
Emory University School of Medicine, Atlanta, GA;
Stanford University Medical Center, Stanford, CA;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.41,
2023,
pp.TPS9143-TPS9143)